Issue Date：June 10, 2022
 

Audit Committee

In order to strengthen the governance, Coretronic established Audit Committee in 2010. The membership of Audit Committee consists of no fewer than three independent directors of the Board.

The Committee meets at least once every quarter. Please consult Coretronic's Annual Report and the market observation post system for the relevant year for the number of meetings convened .

The Audit Committee is responsible to review the following major matters:

 
  • Establish or revise internal control systems and including related policies and procedures
  • Evaluate the performance of the internal control systems
  • Procedures for Handling Material Financial and Business Transactions
  • Matters bearing on the personal interest of a director
  • Material asset or derivatives transactions
  • Material lending funds, endorsements or guarantees
  • Offering, issuance or private placement of any equity-type securities
  • Hiring or dismissal of an attesting CPA, or the compensation given thereto
  • Appointment or discharge of financial, accounting, or internal auditing officers
  • Financial Reports
  • Other important regulations.
The 5th Term of Audit Committee

Tenor: June 10, 2022 to June 09, 2025

Name Position Highest Education & Other Significant Position
Mr. Hsing-Yi Chow Independent Director
  • Ph.D. in Business, Indiana University-Bloomington, US
  • Emeritus Professor, Department of Finance, National Chengchi University
Ms. Audrey Tseng Independent Director
  • Master of Business Administration, Executive MBA of National Taiwan  University and Fudan University
  • Advisory member, Bio Taiwan Committee 
  • Advisory member ,Biotechnology Regulatory Strategy Advisory Council of the Ministry of Health and Welfare
  • Consultant, Biomedical Translation Research Center, Academia Sinica
Mr. Hung-Pin Ku Independent Director
  • BS in Law, National  Taipei University
  • Lawer, KU, HUNG PIN Law Firm

Compensation Committee

In order to strengthen the governance, the Board of Directors of Coretronic decided to establish Compensation Committee in 2012, and appoint the members of Compensation Committee. The membership of Audit Committee consists of three independent directors of the Board.

The Committee meets at least twice a year. Please consult Coretronic's Annual Report and the market observation post system for the relevant year for the number of meetings convened .

The Compensation Committee assists the Board in discharging its responsibilities related to compensation and benefits policies, plans and programs, and in the evaluation of Coretronic's directors of the Board and executives.

 
The 5th Term of Compensation Committee

Tenor: June 10, 2022 to June 09, 2025

Name Position Highest Education & Other Significant Position
Mr. Hsing-Yi Chow Independent Director
  • Ph.D. in Business, Indiana University-Bloomington, US
  • Emeritus Professor, Department of Finance, National Chengchi University
Ms. Audrey Tseng Independent Director
  • Master of Business Administration, Executive MBA of National Taiwan  University and Fudan University
  • Advisory member, Bio Taiwan Committee 
  • Advisory member ,Biotechnology Regulatory Strategy Advisory Council of the Ministry of Health and Welfare
  • Consultant, Biomedical Translation Research Center, Academia Sinica
Mr. Hung-Pin Ku Independent Director
  • BS in Law, National  Taipei University
  • Lawer, KU, HUNG PIN Law Firm
 

Regular Review of Compensations

The functions of the Compensation Committee of the Company are to professionally and objectively evaluate the policies, systems, and performance for compensation of the directors and managerial officers of the Company which includes:

  • Regularly review the “Compensation Committee Charter” and submit recommendations for improvement.
  • Develop and regularly review the long-term performance goals and the policies, systems, criteria, and structure for compensation of the directors and managerial officers of the Company.
  • Regularly review how well the directors and managerial officers achieve their goals, and develop their respective compensation content and amount.

The Compensation Committee hold at least two meetings every year. If necessary, it can hold a meeting anytime and submit recommendations to the Board of Directors for them to make informed decisions.

 


Nominating Committee

The Company established the Nomination Committee in October 2020, which consists of three independent directors, and its member, Xing-Yi Zhou, an independent director with expertise in finance and corporate governance, meets the professional competence required by the committee.
The Nomination Committee was established for the purpose of enhancing the effectiveness of the Company's Board of Directors, and its authority and member list are as follows.

  • Candidates for directors and senior managerial officers are sought, reviewed and nominated based on the criteria of diversified background and independence in terms of professional knowledge, skill, experience, gender required of them.
  • Conduct the performance evaluation of the Board of Directors, each committee and each director, and evaluate the independence of the independent directors.
  • Other matters that the Board of Directors resolved to delegate to this Committee.

The 2nd Term of Nominating Committee

Tenor: June 10, 2022 to June 09, 2025

Name Position Highest Education & Other Significant Position
Mr. Hsing-Yi Chow Independent Director
  • Ph.D. in Business, Indiana University-Bloomington, US
  • Emeritus Professor, Department of Finance, National Chengchi University
Ms. Audrey Tseng Independent Director
  • Master of Business Administration, Executive MBA of National Taiwan  University and Fudan University
  • Advisory member, Bio Taiwan Committee 
  • Advisory member ,Biotechnology Regulatory Strategy Advisory Council of the Ministry of Health and Welfare
  • Consultant, Biomedical Translation Research Center, Academia Sinica
Mr. Hung-Pin Ku Independent Director
  • BS in Law, National  Taipei University
  • Lawer, KU, HUNG PIN Law Firm
● ● ● ● ● ●